IQVIA™ Pharma Deals: Review and Analysis

IQVIA Pharma Deals Review

ISSN 1756-7874. The business journal providing incisive analysis and expert opinion on the major deals.

Pharma Deals Review Latest Articles

GSK Pays US$66 M Upfront for Spero’s Late-Stage Antibiotic Published: 29 Sep-2022
By: Lucy Haggerty
Abstract Fulltext:
Volume: 2022 Issue: 9
Genfit Buys Versantis to Rebuild its Liver Disease Portfolio Published: 21 Sep-2022
By: Lucy Haggerty
Abstract Fulltext:
Volume: 2022 Issue: 9
Zealand Pharma Signs Licensing Agreement with Novo Nordisk for Zegalogue® Published: 21 Sep-2022
By: Ayush Saxena
Abstract Fulltext:
Volume: 2022 Issue: 9
Novo Nordisk to Acquire Forma Therapeutics for US$1.1 B Published: 13 Sep-2022
By: Ashish Tripathi
Abstract Fulltext:
Volume: 2022 Issue: 9
Roche Acquires Good Therapeutics for US$250 M Upfront Published: 10 Sep-2022
By: Lucy Haggerty
Abstract Fulltext:
Volume: 2022 Issue: 9

You can click on any of the bars to open a new page with the corresponding deals.

Login

Login

Username:

Password:

Keep me logged in

Login Problems? Subscribe

Latest Article

GSK Pays US$66 M Upfront for Spero’s Late-Stage Antibiotic

Published: 29 Sep-2022
By: Lucy Haggerty Abstract Fulltext:

DEAL REVIEW OF 2021

Click Here to Access the Article

IQVIA™ Pharma Deals: Review and Analysis